1Fujimoto S, Shrestha RD, Kokubun M, Ohta M,Takahashi M, Kobayashi K, Kiuchi S, Okui K, Miyoshi T, Arimizu N. Intraperitoneal hyperthermic perfusion combined with surgery effective for gastric cancer patients with peritoneal seeding. Ann Surg 1988,208:36-41.
2Ikeguchi M, Oka A, Tsujitani S, Maeta M, Kaibara N. Relationship between area of serosal invasion and intraperitoneal free cancer cells in patients with gastric cancer. Anticancer Res 1994, 14:2131-2134.
3Baskaranathan S, Philips J, McCredden P, Solomon MJ. Free colorectal cancer cells on the peritoneal surface: correlation with pathologic variables and survival. Dis Colon Rectum 2004, 47:2076-2079.
4Marutsuka T, Shimada S, Shiomori K, Hayashi N,Yagi Y, Yamane T, Ogawa M. Mechanisms of peritoneal metastasis after operation for non-serosainvasive gastric carcinoma: an ultrarapid detection system for intraperitoneal free cancer cells and a prophylactic strategy for peritoneal metastasis. Clin Cancer Res 2003,9: 678-685.
5Sayfan J, Averbuch F, Koltun L, Benyamin N. Effect of rectal stump washout on the presence of free malignant cells in the rectum during anterior resection for rectal cancer. Dis Colon Rectum 2000, 43:1710-1712.
6Kodera Y, Yamamura Y, Shimizu Y, Torii A, Hirai T, Yasui K, Morimoto T, Kato T. Peritoneal washing cytology: prognostic value of positive findings in patients with gastric carcinoma undergoing a potentially curative resection. J Surg Oncol 1999, 72:60-64.
7Sugarbaker PH, Mora JT, Carmignani P, Stuart OA,Yoo D. Update on chemotherapeutic agents utilized for perioperative intraperitonaeal chemotherapy.Oncologist 2005, 10. 112-122.
10Ceelen WP, Hesse U, de Hemptinne B, Pattyn P.Hyperthermic intraperitoneal chemoperfusion in the treatment of locally advanced intra-abdominal cancer. Br J Surg 2000; 87:1006-1015.
2Takahashi T, Hagowara A, Shimotsuma M, et al. Prophylaxis and treatment of peritoneal eareinomatosis: intraperitoneal chemotherapy with mitomycin C bound to activated carbon particles[J]. World J Surg, 1995,19 : 265.
3Sugarbaker PH. Rational for early postoperation intraperitoneal chemotherapy as a surgical adjuvant for gastrointestinal malignancy[J]. Regul Cancer Treat, 1989,66.
4Archer S, Gray B. Intraperitoneal 5-fluorouracil infusion for treatment of both peritoneal and liver micrometastases[J]. Sergery, 1990,108(3) :502.
5Surgarbaker PH, Graves T, Debrujin EA, et al. Early postoperative intraperitoneal chemotherapy as an adjuvant therapy to surgery for peritoneal carcinomatoses from gastrointestinal cancer: pharmacological studies [ J ]. Cancer Res, 1990, 108(3) : 5790.
6Dudar JE. Differential response of normal and tumor microcirculation hyperthrmia[J]. Cancer Res, 1994,44:605.
7Tamplins W. Hyperthermic enhancement of antibody complement cytotoxicity for human cells [J]. J Nat Cancer Inst, 1981,66:453.
8Sugarbaker P Ⅱ. Rationale for early postoperative intraperitoneal chemotherapy as a surgical adjuvant for gastrointestinal malignancy. Regul Cancer Treat, 1989; 1:66
9Osker AG. A rationale for carboplatin treatment and abdominal hyperthemia in cancers resticted to peritoneal cavity. Cancer Res, 1992;52:1252
10Iiamazoe R, Matea M, Kaihara N. Intraperitoneal thermochemotherapy for prevention of peritoneal recurrence of gastric cancer: final results of arandomized controlled study. Cancer, 1994; 73(8) :2048
